Pharvaris
PHVS
21 hedge funds and large institutions have $607M invested in Pharvaris in 2023 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 3 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
37% more capital invested
Capital invested by funds: $442M → $607M (+$165M)
0% more funds holding
Funds holding: 21 → 21 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
14.35% less ownership
Funds ownership: 85.49% → 71.14% (-14%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.15M |
| 2 |
VA
VR Adviser
New York
|
+$4.37M |
| 3 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$717K |
| 4 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$324K |
| 5 |
Walleye Capital
New York
|
+$197K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$3.31M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$3.03M |
| 3 |
BCLSI
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
-$1.55M |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$883K |
| 5 |
LCM
Lynx1 Capital Management
San Juan,
Puerto Rico
|
-$321K |
PHVS Hedge Fund Activity: Q3 2023 in Review
21 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q3 2023, worth a combined $607M — up 37% from $442M a quarter earlier.
Fund positioning in PHVS was balanced in Q3 2023: 3 funds opened new positions, 3 closed out, 6 added to existing stakes and 6 trimmed.
The largest buyer was Cormorant Asset Management, adding an estimated $7.15M. The largest seller was Fidelity Investments, cutting an estimated $3.31M.
- 21 institutional investors held Pharvaris (PHVS) as of Q3 2023, unchanged from Q2 2023.
- Funds reported $607M of Pharvaris stock for Q3 2023, up 37% quarter-over-quarter.
- 3 funds opened new Pharvaris positions in Q3 2023 and 3 closed out, a net change of 0 holders.
- The largest Pharvaris buyer in Q3 2023 was Cormorant Asset Management, an estimated $7.15M added.
- The largest Pharvaris seller in Q3 2023 was Fidelity Investments, an estimated $3.31M sold.
Based on aggregated 13F filings for Q3 2023.